FIG. 3 is a schematic diagram of a hybrid capsule in accordance with various embodiments disclosed herein. The hybrid capsule 300 comprises a primary capsule having a shell 302 encapsulating an empty or a loaded/filled core 304 and an organic polymer coating layer 306. In this example, the hybrid capsule has a size/diameter/particle size/particle size distribution/average particle size in the range of from about 5 pm to about 50 pm. Example 2: Primary Capsule(s) Prior to the synthesis of hybrid capsules/polymer reinforced structures, primary capsules stabilised by a surfactant were synthesized. In this example, the primary capsules synthesized were silica hollow microspheres stabilised by cetyltrimethylammonium bromide (CTAB) as the surfactant. 36.4mg of CTAB was dissolved in 100ml_ of deionised (Dl) water in a 250ml_ reaction vessel. The solution was stirred at 600rpm for thirty minutes to ensure that all of the surfactant was dissolved. 10ml_ of n-pentane was injected into the solution and was stirred for thirty minutes at 600rpm. Before the addition of TEOS, light microscopy was taken to ensure that the particles have an average particle size of 30pm. 4ml_ of TEOS was added via a programmed syringe pump at 80pl_/min to the solution. After the addition of TEOS was completed, the stirring speed was lowered to 400rpm. A sample of the solution was taken for analysis using brightfield microscopy. Microscopic images were recorded for four days. SEM analysis was done on day 4. The resultant silica capsules were post processed for other applications. Example 3: Organic Polymer Latex Particles Prior to performing heterocoagulation of organic polymer latex particles with primary capsule(s), organic polymer latex particles were synthesized using emulsion polymerization. In this example, the organic polymer latex particles